Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2020-11-13 Earnings Release
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Wstępne szacunkowe skonsolidowane wyniki finansowe Q3 2020_zał, do ESPI 36/2020
Earnings Release Classification · 100% confidence The document is titled "Wstępne wybrane szacunkowe skonsolidowane dane finansowe Grupy Kapitałowej Selvita S.A. za III kwartał 2020 roku oraz 9 miesięcy 2020 roku" (Preliminary selected estimated consolidated financial data of Selvita S.A. Capital Group for Q3 2020 and 9 months of 2020). It presents key financial metrics (Revenue, EBITDA, Net Profit) for the third quarter and the nine-month period ending September 30, 2020, along with comparative figures. This content strongly indicates a release of periodic financial results, but it explicitly states the data is 'preliminary' and 'estimated' ('szacunkowe'). This aligns best with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it contains detailed tables, the context is an early release before the final, comprehensive report (which is mentioned to be published on November 24, 2020). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial highlight release. It is not a Report Publication Announcement (RPA) because it contains the actual preliminary data, not just an announcement that a report is available. 9M 2020
2020-11-13 Polish
Wstępne wybrane szacunkowe skonsolidowane dane finansowe Grupy Kapitałowej Selvita S.A. za III kwartał 2020 roku oraz zmiana terminu publikacji skonsolidowanego raportu za III kwartał 2020 roku - C...
Report Publication Announcement Classification · 95% confidence The document text, written in Polish, announces a change in the publication date for the Q3 2020 consolidated interim report (ródroczny skonsolidowany raport za III kwartał 2020 roku). Crucially, the text states: 'Jednocześnie Emitent przekazuje w załączeniu do niniejszego raportu bieżącego wstępne szacunkowe wyniki finansowe...' (At the same time, the Issuer provides in the attachment to this current report preliminary estimated financial results...). Because the document is very short (598 chars) and its primary function is to announce a change in schedule AND attach preliminary results, it fits the definition of a Report Publication Announcement (RPA) or a Regulatory Filing (RNS). Since it specifically mentions the publication/attachment of preliminary results related to an interim report, RPA is a strong candidate, but given the context of announcing a schedule change for a formal report (which is often handled via RNS in many jurisdictions), and the attachment of preliminary data, RNS (General Regulatory Announcement) is the most appropriate fallback for an announcement about the timing/publication of results, especially when preliminary figures are attached rather than the full report itself. Given the options, RPA (Report Publication Announcement) is the most precise fit for announcing the publication/attachment of results related to a scheduled report.
2020-11-13 Polish
Drugie wezwanie do złożenia dokumentów akcji - Content (PL)
Regulatory Filings Classification · 90% confidence The document text is very short (496 characters) and appears to be a formal notice from the Management Board ('Zarząd') of Selvita S.A. The content explicitly calls upon shareholders holding specific registered shares (Series A) to submit their physical share certificates for dematerialization, citing a specific Polish law from 2019 regarding the dematerialization of shares. This action relates to changes in the company's capital structure or share registration process. Given the options, this is a specific regulatory/corporate action announcement. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It most closely relates to a capital structure change or a specific corporate action announcement. Since it is a formal notice regarding the status/form of shares, 'Share Issue/Capital Change' (SHA) is a possibility, but 'Regulatory Filings' (RNS) serves as a strong fallback for specific, non-standard corporate notices that don't fit the primary categories like ER, 10-K, or DIV. Given the nature of the announcement (a mandatory call for share dematerialization based on new legislation), it is a specific corporate action announcement. However, since there isn't a perfect fit for 'Share Dematerialization Notice,' and it is a formal regulatory communication, RNS is the most appropriate general category for specific, non-standard regulatory announcements.
2020-10-23 Polish
Rekomendowanie projektu Centrum Badawczo-Rozwojowe Usług Laboratoryjnych w Obszarze Odkrywania i Rozwoju Leków Selvita S.A. do dofinansowania - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text is a formal announcement from the Management Board ('Zarząd') of Selvita S.A. regarding the successful application for significant government funding (dofinansowanie) for a new Research and Development Center ('Centrum Badawczo-Rozwojowego'). This announcement details the project scope, the amount of funding received (41.26 million PLN), the total project cost (145 million PLN), and the relevant operational program (Program Operacyjny Inteligentny Rozwój 2014-2020). This content directly relates to the company's fundraising, financing activities, and capital structure/investment plans. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific financing event.
2020-10-01 Polish
Pierwsze wezwanie do złożenia dokumentów akcji - Content (PL)
Regulatory Filings Classification · 99% confidence The document text is very short (499 characters) and appears to be a formal notice from the Management Board ('Zarząd') of Selvita S.A. The content explicitly calls upon shareholders holding specific registered shares (Series A) to submit their physical share certificates for dematerialization, citing a specific Polish law (Ustawa z dnia 30 sierpnia 2019 roku). This is a specific corporate action announcement related to share structure/registration, but it does not fit neatly into the primary categories like 10-K, ER, or DIV. It is a formal regulatory/corporate announcement that doesn't match the specific definitions for DIRS, DVA, SHA, or POS. Given the nature of a formal, specific corporate notice that doesn't fit other precise categories, the most appropriate fallback is the general Regulatory Filings category (RNS).
2020-09-30 Polish
Zawiadomienie_art. 69_Selvita
Major Shareholding Notification Classification · 99% confidence The document is titled "ZAWIADOMIENIE O ZMIANIE STANU POSIADANEGO UDZIAŁU W OGÓLNEJ LICZBIE GŁOSÓW W SPOŁCE" (Notification of a change in the share of the total number of votes in the company). It explicitly references Polish law regarding public offerings and significant shareholdings (art. 69 ust. 1 pkt 2) w zw. z art. 69a ust 1 pkt 1) ustawy z dnia 29 lipca 2005 r. o ofercie publicznej...). It details the change in the percentage of votes held by AUGEBIT Fundusz Inwestycyjny Zamknięty from 5.19% to 4.64% following a capital increase by the target company. This type of filing, reporting changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ).
2020-09-10 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.